CRISPR

Risk Mitigation Strategies For Gene Therapy Developers

In recent weeks, a handful of scientific articles in peer-reviewed medical literature, as well as alarmist headlines in the popular press, have …

Genetic Engineering

Synthetic Bio continues slide, down 15%

Nano cap Synthetic Biologics (SYN -14.8%) is down on below-average volume. Shares have lost almost 65% of their value since announcing a 1:35 reverse …

Business

CRISPR First Look At June 2018 Updates

<i>ISTOCK, BUBAONE</i><p>We obtained approval of Clinical Trial Applications (CTA) in multiple countries for both β-thalassemia and sickle cell disease (SCD) …

Business

What will the Doctor order?

By Melissa Hogenboom<p>Our quest to understand how our genes work started in earnest in the mid-19th Century when a biologist and monk called Gregor Mendel came to a startling conclusion about the traits of plants. He crossed purple flowered pea plants with white ones, and found that all the resulting …

Genetics

Opinion: Using CRISPR for the ‘smaller wins,’ like making chemotherapy less toxic

Although the phrase “war on cancer” was first uttered in 1971, the breakthroughs in biomedical research that have emerged during this decade have …

Genetics

Kidney CRISPR: How Close Are We?

CRISPR (clustered regularly interspaced short palindromic repeats) gene editing is making huge waves in biomedical research. In fact, the lay press …

Genetic Engineering

CRISPR Can Track Cellular History of a Mammalian Embryo

Researchers used the genome-editing technology to analyze the development of mouse tissues.

Genetics

CRISPR Method Dramatically Improves Gene Editing Delivery to Mosquitoes

The recent abundance of studies and ensuing data associated with the CRISPR genome editing system would lead some to believe that use of this …

Genetics

Wachtel Award Honors Two Innovative Cancer Researchers

Neville Sanjana (left), Tom Misteli, Omer Yilmaz, Yevgeniya Nusinovich, and AAAS CEO Rush Holt at the Wachtel Awards ceremony at the National …

Cancer

CRISPR ‘barcodes’ map mammalian development in exquisite detail

NEWS<p>09 August 2018<p>Genome-editing technique enables researchers to trace lineage of cells in developing mice.<p>Search for this author in:<p>Pub …

Genetics

Is CRISPR Gene Editing Doomed, Even As Gene Therapy Enters the Clinic? | DNA Science Blog

Anyone watching the recent <i>60 Minutes</i> segment on CRISPR would conclude that the gene editing technology is on the brink of pouring forth a cascade of …

Genetics

Why Gene Editing Is the Next Food Revolution

Environment<p>Crispr has the potential to boost yields, disease resistance, and taste, and even tackle allergens like gluten. It could radically change how we breed and grow crops—and scientists say they're working only with nature's tools.<p>Tucked into a suburban Long Island neighborhood, a 12-acre …

Genetics

Those CRISPR’d human embryos? We got it right, scientists insist

Shoukhrat Mitalipov of Oregon Health and Science University and his colleagues report that they re-tested the embryos — and got the same results.

Genetics

CRISPR/Cas9 players give up gains on (another) report of off-target effects

The research paper rollercoaster continues for CRISPR/Cas9 gene editors Editas Medicine (EDIT +3.1%), CRISPR Therapeutics (CRSP +2%) and Intellia …

Business

Scientists Take a Harder Look at Genetic Engineering of Human Embryos

The distant future of designer babies might not seem so distant after all. The last year has been full of news about genetic engineering—much of it …

Genetics

Visa, Zuora, CRISPR, Tractor Supply: 'Mad Money' Lightning Round

Here's what Jim Cramer had to say about some of the stocks during the <i>Mad Money Lightning Round</i>:<p>Visa (V) : "Visa and Mastercard (MA) have both been …

Investing

BREAKING: Flagship's Latest Venture Inari Raises $40m Series B to "Transform Plant Breeding"

Inari, the latest venture from venture development organization Flagship Pioneering, has raised $40 million in Series B funding.<p>The company describes …

Is Crispr Therapeutics Stock Grossly Overvalued?

Despite a wave of bad news for gene-editing companies employing the CRISPR/Cas 9 system as of late, shares of <b>Crispr Therapeutics</b> (NASDAQ: CRSP) have …

Genetics

Gene-Editing Technique in Human Embryos Draws Skepticism

Critics challenge a study saying a disease-causing gene mutation was repaired in human embryos<p>Scientists are challenging a high-profile study that found a popular gene-editing tool could be used to repair a disease-causing mutation in human embryos.<p>Two papers published in the journal Nature on …

Genetics

OHSU's Mitalipov confirms earlier gene editing breakthrough after critics raise doubts - Portland Business Journal

By Elizabeth Hayes <br>– Staff Reporter, Portland Business Journal<p>Aug 8, 2018, 10:15am PDT<b><br>Updated</b> Aug 8, 2018, 10:51am PDT<p>Just weeks after an Oregon …

Genetics

Potato Company Simplot Licenses DowDuPont’s Gene Editing Tech

By Dan Nosowitz<p>The agricultural company J.R. Simplot Company, one of the largest potato producers in the world, struck a deal with the developers of …

Genetics

We can change human DNA. We're just not sure which bits

It points to a huge problem with genetic editing: it is easy to cut out one gene, but very difficult to be 100 per cent sure other genes weren’t …

Genetics

Researchers say CRISPR edits to a human embryo worked. But critics still doubt it

When researchers announced last year that they had edited human embryos to repair a damaged gene that can lead to heart failure, critics called the …

Genetics

Large deletions induced by Cas9 cleavage

Brief Communications Arising | Published: 08 August 2018<p><i>Nature</i><b>volume 560</b>, pagesE8–E9 (2018) | Download Citation<p>ARISING FROM H. Ma et al. <i>Nature</i> <b>548</b>, …

Google Scholar

US scientist who edited human embryos with CRISPR responds to critics - MIT Technology Review

Facing criticism from fellow scientists, the researcher behind the world’s largest effort to edit human embryos with CRISPR is vowing to continue his …

Genetics

Did CRISPR really fix a genetic mutation in these human embryos?

NEWS<p>08 August 2018<p>Researchers provide more evidence for their landmark claim that gene editing rid embryos of a disease mutation — but scientists are …

Genetics

CRISPR Therapeutics misses by $0.19, misses on revenue

CRISPR Therapeutics (NASDAQ:CRSP): Q2 EPS of -$0.82 misses by $0.19.<p>Revenue of $1.09M (-69.6% Y/Y) misses by $0.74M.<p>Shares -1.21% AH.<p>Press Release<p>Now …

Business

CRISPR/Cas in Agrisciences, 2018 Market Research Report - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--<p>The "CRISPR/Cas in Agrisciences" report has been added to <b>ResearchAndMarkets.com's</b> offering.<p>Over the last few decades, Gene …

Genetics

Allergan to Develop Editas CRISPR Therapy EDIT-101 for LCA10

Allergan plans to develop and commercialize Editas Medicine’s CRISPR genome editing treatment candidate EDIT-101 globally for Leber Congenital …

Chemical Engineering

CRISPR licensing deal could lead to better traits in food, reduce waste

J.R. Simplot is borrowing the technology from DowDuPont, Harvard and MIT, but it will likely be several years before new products reach the …

Agriculture